Hennion & Walsh Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-84,259
| Closed | -$2.28M | – | 820 |
|
|
2022
Q3 | $2.28M | Sell |
84,259
-4,761
| -5% | -$129K | 0.15% | 177 |
|
|
2022
Q2 | $1.23M | Sell |
89,020
-4,136
| -4% | -$57.1K | 0.08% | 270 |
|
|
2022
Q1 | $1.82M | Sell |
93,156
-3,353
| -3% | -$65.4K | 0.1% | 232 |
|
|
2021
Q4 | $1.58M | Sell |
96,509
-8,824
| -8% | -$144K | 0.08% | 270 |
|
|
2021
Q3 | $2.94M | Sell |
105,333
-2,323
| -2% | -$64.7K | 0.15% | 192 |
|
|
2021
Q2 | $3.19M | Buy |
107,656
+14,865
| +16% | +$441K | 0.17% | 173 |
|
|
2021
Q1 | $2.59M | Buy |
+92,791
| New | +$2.59M | 0.16% | 184 |
|